Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bowel (colorectal) cancer, Secondary cancers
Closed
Phase 3
This trial is comparing lenvatinib and pembrolizumab with for bowel cancer that has spread (advanced bowel cancer).
It is for people whose cancer has spread and continued to grow during treatment. It is also for people whose cancer came back after treatment and surgery to remove it is not possible.
Recruitment start: 20 July 2021
Recruitment end: 28 December 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Kai Keen Shiu
Merck Sharp & Dohme Ltd
Last reviewed: 3 September 2024
CRUK internal database number: 17601
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
